MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jfda.2019.09.004

Медицинская библиотека · Journal of food and drug analysis · 2019

NeuroDefend, a novel Chinese medicine, attenuates amyloid-β and tau pathology in experimental Alzheimer's disease models.

Iyaswamy Ashok, Krishnamoorthi Senthil Kumar, Song Ju-Xian, Yang Chuan-Bin, Kaliyamoorthy Venkatapathy, Zhang Huan, Sreenivasmurthy Sravan G, Malampati Sandeep, Wang Zi-Ying, Zhu Zhou, Tong Benjamin Chun-Kit, Cheung King-Ho, Lu Jia-Hong, Durairajan Siva Sundara Kumar, Li Min

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

Alzheimer's disease (AD) is the most common age-related neurodegenerative disorder. Amyloid-β (Aβ) and hyper-phosphorylated tau accumulation are accountable for the progressive neuronal loss and cognitive impairments usually observed in AD. Currently, medications for AD offer moderate symptomatic relief but fail to cure the disease; hence development of effective and safe drugs is urgently needed for AD treatment. In this study, we investigated a Chinese medicine (CM) formulation named NeuroDefend (ND), for reducing amyloid β (Aβ) and tau pathology in transgenic AD mice models. Regular oral administration of ND improved cognitive function and memory in 3XTg-AD and 5XFAD mice. In addition, ND reduced beta-amyloid precursor protein (APP), APP C-terminal fragments (CTF-β/α), Aβ and 4G8 positive Aβ burden in 3XTg-AD and 5XFAD mice. Furthermore, ND efficiently reduced the levels of insoluble phospho-tau protein aggregates and AT8 positive phospho tau neuron load in 3XTg-AD mice. Hence, ND could be a promising candidate for the treatment of AD in humans.

Для цитирования: Iyaswamy Ashok, Krishnamoorthi Senthil Kumar, Song Ju-Xian, Yang Chuan-Bin, Kaliyamoorthy Venkatapathy, Zhang Huan, Sreenivasmurthy Sravan G, Malampati Sandeep, Wang Zi-Ying, Zhu Zhou, Tong Benjamin Chun-Kit, Cheung King-Ho, Lu Jia-Hong, Durairajan Siva Sundara Kumar, Li Min. NeuroDefend, a novel Chinese medicine, attenuates amyloid-β and tau pathology in experimental Alzheimer's disease models.. Journal of food and drug analysis. 2019. DOI: 10.1016/j.jfda.2019.09.004.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.